FGL2 and neoplasm: FGL2 not only exerts prothrombinase activity directly catalyzing the conversion of prothrombin into thrombin 14, but also performs potent immunoregulatory functions in a variety of diseases, including autoimmune disorders, xenograft rejection, viral-induced inflammation, chronic obstructive pulmonary disease, and tumor growth 15-19.